Login / Signup

Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers.

Benjamin GarmezyJinesh S GheeyaHeather Y LinYuefan HuangTaebeom KimXian-Li JiangKyaw Zin TheinPatrick G PiliéFadl ZeineddineWanlin WangKenna Rael ShawJordi Rodon AhnertJohn Paul ShenYing YuanFunda Meric-BernstamKen ChenTimothy A Yap
Published in: JCO precision oncology (2022)
mutation as a predictive biomarker of ICI therapy.
Keyphrases
  • stem cells
  • bone marrow
  • cell therapy